Press release
Leading Element Driving Change in the Digital Dose Inhalers Market in 2025: Rising Prevalence Of Chronic Respiratory Diseases Fuels Growth In The Digital Dose Inhaler Market Driver
Digital Dose Inhalers Market Growth
The market size of digital dose inhalers has experienced exponential growth in the past few years. The growth is forecasted to continue from $19.6 billion in 2024 to $23.94 billion in 2025, with a compound annual growth rate (CAGR) of 22.2%. This impressive growth in the historic period is credited to factors such as the rise in respiratory illnesses, higher usage of digital dose inhalers, growing necessity for accurate monitoring of dosing times and dates, increasing elderly population, and a greater focus placed on personalized healthcare.
The market size of digital dose inhalers is projected to observe significant expansion in the upcoming years, growing to a massive $52.82 billion in size by 2029 with a compound annual growth rate (CAGR) of 21.9%. The anticipated growth during the forecast timeframe can be linked to factors like the emergence of telemedicine, a rise in the incidence of respiratory ailments, a growing demand for better adherence and management of medication, and an increase in consumer awareness. The prominent trends for the forecast period are projected to be the incorporation of digital technology, enhancement of consumer knowledge and enlightenment, financial feasibility, integration with IoT and AI, and expansion of telemedicine.
What Is Stimulating Growth in the Digital Dose Inhalers Market?
The increase in chronic respiratory diseases is anticipated to drive the advancement of the digital dose inhalers market in the future. Chronic respiratory conditions, which involve prolonged issues with the lungs and airways leading to uninterrupted breathing problems, are becoming more common. This rise can be linked to several elements, such as growing air pollution, an aging demographic, and escalating tobacco consumption. Digital dose inhalers are crucial in enhancing medication compliance and tracking for patients with conditions like asthma and chronic obstructive pulmonary disease (COPD). For instance, in June 2024, data from 2022 suggested that about 8.5 million Australians, or 34% of the population, were reported by the Australian Government to likely be suffering from chronic respiratory issues. This comprises nearly 2.8 million individuals (11%) who have asthma, and approximately 638,000 people (2.5%) believed to have COPD. Thus, this increment in chronic respiratory diseases is stimulating the expansion of the digital dose inhalers market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18807&type=smp
Who Are the Dominant Companies Influencing Digital Dose Inhalers Market Trends?
Major companies operating in the digital dose inhalers market are AstraZeneca plc, Novartis AG, 3M Company, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., C.H. Boehringer Sohn AG & Co. KG, AptarGroup Inc., Cipla Limited, Chiesi Farmaceutici S.p.A., Lupin Limited, Glenmark Pharmaceuticals Limited, OPKO Health Inc., Nemera, Sensirion AG, Sunovion Pharmaceuticals Inc., MannKind Corporation, Adherium Limited, H&T Presspart, Monaghan Medical Corporation, BreatheSuite Inc.
How Is the Digital Dose Inhalers Market Evolving?
Significant players in the digital dose inhalers market are concentrating on the development of pioneering products like smart inhalers in order to enhance patient results and refine medication management. These smart inhalers are sophisticated devices that possess sensors and connectivity features, supporting the monitoring of drug consumption, inhalation methods, and adherence while supplying instantaneous feedback through mobile apps. For example, in June 2024, the UK-based Aseptika Ltd. unveiled the PUFFClicker3 universal smart inhaler dose tracker at the Med-Tech Innovation Expo. This is the first inhaler dose tracker in the world that is compatible with both pressurized metered dose inhalers (pMDI) and dry powder inhalers (DPI), and accommodates 101 SNOMED-coded inhaler types. This invention eases the shift between various inhaler types for patients and provides integrated visual instructions for each supported inhaler.
What Are the Different Segmentations in the Digital Dose Inhalers Market?
The digital dose inhalers market covered in this report is segmented -
1) By Product: Metered Dose Inhaler (MDI), Dry Powder Inhaler (DPI)
2) By Type: Branded Medication, Generic Medication
3) By Indications: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Other Indications
4) By End User: Medical Device Industry, Hospital
Subsegments:
1) By Metered Dose Inhaler (MDI): Conventional MDI, Smart MDI
2) By Dry Powder Inhaler (DPI): Single-Dose DPI, Multi-Dose DPI, Smart DPI
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/digital-dose-inhalers-global-market-report
Which Region Is at the Forefront of the Digital Dose Inhalers Market?
North America was the largest region in the digital dose inhalers market in 2024. Asia-Pacific is expected to be the fastest-growing region inthe forecast period. The regions covered in the digital dose inhalers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Digital Dose Inhalers Global Market Report?
- Market Size Analysis: Analyze the Digital Dose Inhalers Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Digital Dose Inhalers Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Digital Dose Inhalers Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Digital Dose Inhalers Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18807
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Element Driving Change in the Digital Dose Inhalers Market in 2025: Rising Prevalence Of Chronic Respiratory Diseases Fuels Growth In The Digital Dose Inhaler Market Driver here
News-ID: 3860124 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Dose
Auto Disable Syringe with Fixed Dose.
Introducing the revolutionary WHO PQS CE approved 0.1ml fixed dose auto-disabling syringe [https://www.lingyang-medical.com/auto-disable-syringe/], a game changer for the medical community. This state-of-the-art syringe combines advanced technology and innovative design to provide healthcare professionals with a safe and reliable drug delivery solution.
WHO PQS certification ensures that the syringe meets the highest quality and safety standards set by the World Health Organization. This recognition demonstrates the syringe's ability to deliver accurate and…
North America Leads the Surge in Metered-Dose Inhalers Market Adoption | Metered …
The Global Metered-Dose inhalers Market reached US$ 16.6 billion in 2023 and is expected to reach US$ 24.18 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2025-2033.
The Metered-Dose Inhalers (MDI) Market focuses on drug delivery devices used in managing respiratory disorders like asthma and COPD. MDIs provide precise, portable, and fast-acting medication administration. The market is expanding due to growing respiratory disease incidence and environmental…
Global Radiation Dose Management Platform Market Size by Application, Type, and …
According to Market Research Intellect, the global Radiation Dose Management Platform market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The Radiation Dose Management Platform Market is witnessing notable growth due to increasing awareness around patient…
Radiation Dose Management Market Report 2024 - Radiation Dose Management Market …
"The Business Research Company recently released a comprehensive report on the Global Radiation Dose Management Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Radiation Dose Management Market Report by Product & Service (Radiation Dose Man …
Global Radiation Dose Management Market
The global radiation dose management market is projected to experience significant growth, expanding from US$330.87 million in 2023 to US$1,004.39 million by 2032. This represents a compound annual growth rate (CAGR) of 13.13% from 2024 to 2032, driven by factors such as the increasing prevalence of diseases like cancer, rapid growth in the healthcare sector, and investments in research and development.
Orthopedic Prosthetics Market Table of Content…
Radiation Dose Management Market - Radiation Dose Tracking Excellence: Elevating …
Newark, New Castle, USA: The "Radiation Dose Management Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Radiation Dose Management Market: https://www.growthplusreports.com/report/radiation-dose-management-market/8706
This latest report researches the industry structure,…
